Experience with prostaglandin E2 in obstetric practice.
Mehta
A
A
Popat
N
N
D000019:Abortifacient Agents; D000028:Abortion, Induced; D001208:Asia; D001695:Biology; D036861:Delivery, Obstetric; D003906:Developing Countries; D004703:Endocrine System; D005069:Evaluation Studies as Topic; D005193:Family Planning Services; D007194:India; D010827:Physiology; D011247:Pregnancy; D011248:Pregnancy Complications; D011256:Pregnancy Outcome; D011262:Pregnancy Trimester, Second; D011263:Pregnancy Trimester, Third; D011453:Prostaglandins; D012098:Reproduction
D000019:Abortifacient Agents; D011453:Prostaglandins
Abortifacient Agents; Abortion, Drug Induced; Abortion, Induced; Asia; Biology; Delivery; Developing Countries; Endocrine System; Evaluation; Family Planning; Fertility Control, Postconception; India; Physiology; Pregnancy; Pregnancy Complications; Pregnancy Outcomes; Pregnancy, Second Trimester; Pregnancy, Third Trimester; Prostaglandins--administraction and dosage; Prostaglandins--side effects; Reproduction; Southern Asia